| Page 4 | Kisaco Research

As the UPC enters its third year, litigants are increasingly testing the interplay between UPC actions and EPO oppositions. While UPC decisions are not binding on the EPO, both institutions stress the need for legal certainty and efficiency—yet divergent outcomes are still possible. This session examines how parties are using parallel tracks not only to defend or attack patents but also to shape settlement dynamics, licensing leverage, and litigation timing.

  • Understand when the UPC is likely to stay proceedings in light of parallel EPO oppositions, including guidance from Astellas v. Healios, Toyota Motor v. Neo Wireless, Carrier v. Bitzer and Edwards v. Meril.
  • Analyse the strategic implications of conflicting outcomes where the UPC and EPO maintain different amended forms of a patent.
  • Explore tactical advantages for opponents in filing both EPO oppositions and UPC revocation actions, including accelerated proceedings and increased pressure on patentees.
  • Evaluate how timing choices—whether simultaneous filings or staggered actions—can influence settlement leverage and long-term portfolio strategy.
 

Okan Can

Senior Partner
Deris

Okan Can

Senior Partner
Deris

Okan Can

Senior Partner
Deris
 

Gary Moss

Chairman
EIP

Gary Moss

Chairman
EIP

Gary Moss

Chairman
EIP
 

Carl-Alexander Dinges

Partner
Bonabry

Carl-Alexander Dinges

Partner
Bonabry

Carl-Alexander Dinges

Partner
Bonabry
 

Cilon Li

Sr. Director of Engineering, Digital Products Development
Cytiva

Cilon Li is a digital and IT executive with over 15 years of experience in healthcare and biopharma. He is a strategic leader with a proven track record in driving digital transformation across supply chain management, product management, and R&D. At Cytiva, Cilon drives the company’s digital strategy and expanding product portfolio, encompassing Internet of Things (IoT), data analytics, AI/ML, software as a service (SaaS) and enterprise applications to help customers progress their digital biomanufacturing journeys. 

Cilon Li

Sr. Director of Engineering, Digital Products Development
Cytiva

Cilon Li

Sr. Director of Engineering, Digital Products Development
Cytiva

Cilon Li is a digital and IT executive with over 15 years of experience in healthcare and biopharma. He is a strategic leader with a proven track record in driving digital transformation across supply chain management, product management, and R&D. At Cytiva, Cilon drives the company’s digital strategy and expanding product portfolio, encompassing Internet of Things (IoT), data analytics, AI/ML, software as a service (SaaS) and enterprise applications to help customers progress their digital biomanufacturing journeys. 

 

Tobias Hahn, PhD

R&D Director
GoSilico

Tobias Hahn is R&D Director of chromatography mechanistic modeling activities at Cytiva. As former co-founder and CEO of GoSilico, now part of Cytiva, Tobias is responsible for delivering simulation software and workflows for in silico process development. He received his undergraduate education in computational mathematics and technical physics in Karlsruhe and Stockholm, earning his PhD in chemical engineering from Karlsruhe Institute of Technology (KIT).

Tobias Hahn, PhD

R&D Director
GoSilico

Tobias Hahn, PhD

R&D Director
GoSilico

Tobias Hahn is R&D Director of chromatography mechanistic modeling activities at Cytiva. As former co-founder and CEO of GoSilico, now part of Cytiva, Tobias is responsible for delivering simulation software and workflows for in silico process development. He received his undergraduate education in computational mathematics and technical physics in Karlsruhe and Stockholm, earning his PhD in chemical engineering from Karlsruhe Institute of Technology (KIT). During his doctoral studies, he utilized his background in mathematics and software engineering to create the simulation software now known as GoSilico™ chromatography modeling software.

 

Courtney Miller

Chief Veterinary & Innovation Officer
Vetnique

Courtney Miller

Chief Veterinary & Innovation Officer
Vetnique

Courtney Miller

Chief Veterinary & Innovation Officer
Vetnique